Citation: T. Levent et al., Policies used to control multidrug resistant organisms: personnel and equipment resources in the Nord-Pas de Calais region., MED MAL INF, 31(1), 2001, pp. 19-24
Authors:
Legout, L
Maulin, L
Senneville, E
Leduc, L
Leroy, O
Georges, H
Guery, B
Beaucaire, G
Mouton, Y
Citation: L. Legout et al., Mycobacterial sepsis following instillation of intravesical Calmette-Guerin bacillus. Is corticosteroidal therapy necessary?, MED MAL INF, 31(1), 2001, pp. 29-32
Authors:
Viget, NB
Guery, BPH
Ader, F
Neviere, R
Alfandari, S
Creuzy, C
Roussel-Delvallez, M
Foucher, C
Mason, CM
Beaucaire, G
Pittet, JF
Citation: Nb. Viget et al., Keratinocyte growth factor protects against Pseudomonas aeruginosa-inducedlung injury, AM J P-LUNG, 279(6), 2000, pp. L1199-L1209
Authors:
Auboyer, C
Beaucaire, G
Drugeon, H
Gouin, F
Granry, JC
Jarlier, V
Korinek, AM
Martin, C
Montravers, P
Pottecher, T
Pourriat, JL
Schlemmer, B
Stahl, JP
Wolff, M
Citation: C. Auboyer et al., Combination of antibiotics or monotherapy in ICU and surgery. Guidelines of the Societe francaise d'anesthesie et de reanimation, MED MAL INF, 30(4), 2000, pp. 185-190
Citation: S. Alfandari et G. Beaucaire, Comments on the report of the BSAC Working Party (WP) on self-medication of antibacterials without prescription, J ANTIMICRO, 45(1), 2000, pp. 129-130
Authors:
Georges, H
Leroy, O
Guery, B
Alfandari, S
Beaucaire, G
Citation: H. Georges et al., Predisposing factors for nosocomial pneumonia in patients receiving mechanical ventilation and requiring tracheotomy, CHEST, 118(3), 2000, pp. 767-774
Authors:
Guery, B
Neviere, R
Viget, N
Foucher, C
Fialdes, P
Wattel, F
Beaucaire, G
Citation: B. Guery et al., Inhaled NO preadministration modulates local and remote ischemia-reperfusion organ injury in a rat model, J APP PHYSL, 87(1), 1999, pp. 47-53
Authors:
Leroy, O
Guilley, J
Georges, H
Choisy, P
Guery, B
Alfandari, S
Beaucaire, G
Citation: O. Leroy et al., Effect of hospital-acquired ventilator-associated pneumonia on mortality of severe community-acquired pneumonia, J CRIT CARE, 14(1), 1999, pp. 12-19
Authors:
Beaucaire, G
Nicolas, MH
Martin, C
Offenstadt, G
Philippon, A
Holzapfel, L
Pean, Y
Leophonte, P
Le Fur, D
Renard, S
Citation: G. Beaucaire et al., Phare study. Comparative study of the association cefepime-amikacin versusthe association ceftazidime-amikacin in the treatment of nosocomial pneumonias in ventilated patients, ANN FR A R, 18(2), 1999, pp. 186-195
Authors:
Alfandari, S
Guery, B
Senneville, E
Georges, H
Leroy, O
George, O
Coignard, C
Caillaux, M
Beaucaire, G
Citation: S. Alfandari et al., Decrease of antibiotic use after the introduction of time-limited prescription forms, MED MAL INF, 29(9), 1999, pp. 567-572
Authors:
Cattoen, C
Levent, T
Grandbastien, B
Descamps, D
Bouillet, L
Coignard, B
Beaucaire, G
Citation: C. Cattoen et al., Regional survey of Pseudomonas aeruginosa in northern France: epidemiological and microbiological data., MED MAL INF, 29(3), 1999, pp. 160-166
Authors:
Georges, H
Leroy, O
Vandenbussche, C
Guery, B
Alfandari, S
Tronchon, L
Beaucaire, G
Citation: H. Georges et al., Epidemiological features and prognosis of severe community-acquired pneumococcal pneumonia, INTEN CAR M, 25(2), 1999, pp. 198-206
Authors:
Tod, M
Minozzi, C
Beaucaire, G
Ponsonnet, D
Cougnard, J
Petitjean, O
Citation: M. Tod et al., Isepamicin in intensive care unit patients with nosocomial pneumonia: population pharmacokinetic-pharmacodynamic study, J ANTIMICRO, 44(1), 1999, pp. 99-108
Authors:
Leroy, O
Devos, P
Guery, B
Georges, H
Vandenbussche, C
Coffinier, C
Thevenin, D
Beaucaire, G
Citation: O. Leroy et al., Simplified prediction rule for prognosis of patients with severe community-acquired pneumonia in ICUs, CHEST, 116(1), 1999, pp. 157-165
Authors:
Leroy, O
Bosquet, C
Vandenbussche, C
Coffinier, C
Georges, H
Guery, B
Alfandari, S
Thevenin, D
Beaucaire, G
Citation: O. Leroy et al., Community-acquired pneumonia in the intensive care unit: Epidemiological and prognosis data in older people, J AM GER SO, 47(5), 1999, pp. 539-546